Direxion Daily AAPL Bear 1X Shares (NASDAQ: AAPD)

에 대한 최신 뉴스 Direxion Daily AAPL Bear 1X Shares (NASDAQ:AAPD)

Direxion Daily AAPL Bear 1X Shares

Direxion

The Fund, under normal circumstances, invests in financial instruments, including swap agreements and options, that, in combination, provide inverse (opposite) or short leveraged exposure to AAPL equal to at least 80 percent of the Funds net assets (plus borrowings for investment purposes).

Dreyfus Govt Cash Man Ins

Gs Financial Square Treasury Instruments Fund

Dreyfus Trsy Prime Cash Mgmt - In 0 -

Goldman Sachs Fin Gov 465 Institut

Palantir

Long Ideas

Macro Economic Events

Broad U.S. Equity ETFs

Specialty ETFs

Economics

Exclusives

Tech

Trading Ideas

Interview

ETFs

AAPD

PLTD

PLTR

PLTU

SOXL

Direxion Daily Semiconductor Bear 3X Shares

SOXS

YANG

AI 과대광고, 관세 공포, 지정학적 헤드라인에 휩싸인 시장에서 오늘날 트레이더는 관망하지 않고 변동성을 바로 보고 빠르게 움직이고 있다. 디렉시온(Direxion)의 자본시장 책임자인 제이크 베한(Jake Behan)은 벤징가와 독점 Q&amp;A 이메일에서 가장 적극적인 시장 참여자들은 레버리지 및 인버스 ETF를 이용해 장기적인 관점이 아닌 빠르고 확신에 찬 움직임을 보이고 있다고 전했다. 

변동성 즐기는 기술 트레이더들의 거래···완벽한 사례는 바로 팔란티어

WIIM

Orchestra BioMed Holdings, Inc. - Ordinary Shares

OBIO

Orchestra BioMed shares are trading higher after the company reported better-than-expected Q1 sales results.

VCIG

VCI Global shares are trading higher following a year-over-year increase in FY24 sales results.

Oppenheimer analyst Andreas Argyrides maintains ProQR Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRQR#NASDAQ">PRQR</a>) with a Outperform and lowers the price target from $15 to $9.

News

Price Target

Analyst Ratings

PRQR

Oppenheimer Maintains Outperform on ProQR Therapeutics, Lowers Price Target to $9

KPTI

Karyopharm Therapeutics shares are trading lower after several firms cut their respective price targets on the stock.

MASS

908 Devices shares are trading lower following a Q1 sales miss and FY25 issued sales guidance below estimates.

ELSE

Electro-Sensors shares are trading higher following Q1 reported financial results.

<a href="https://truthsocial.com/@realDonaldTrump/posts/114501759958997511" title="https://truthsocial.com/@realDonaldTrump/posts/114501759958997511">https://truthsocial.com/@realDonaldTrump/posts/114501759958997511</a>

Federal Reserve

President Trump Posts On Truth Social "No Inflation, and Prices of Gasoline, Energy, Groceries, and practically everything else, are DOWN!!! THE FED must lower the RATE, like Europe and China have done. What is wrong with Too Late Powell? Not fair to America, which is ready to blossom? Just let it all happen, it will be a beautiful thing!"

Natural Gas Services Group shares are trading higher after the company reported better-than-expected Q1 financial results.

May 13, 2025
RIYADH
Qualcomm Technologies, Inc. and Aramco Digital announced their intent to enter into a strategic collaboration to develop, deploy and commercialize state-of-the-art edge AI industrial IoT technologies and solutions, which will drive the digital transformation of key industries in the Kingdom of Saudi Arabia. The collaboration also covers the development of AI industrial use-cases and service offerings.
Aramco Digital will aim to develop and commercialize a range of advanced edge AI industrial devices and end-to-end solutions powered by products and services from Qualcomm Technologies. These solutions will help meet the specific requirements of various industry sectors in the Kingdom, and are designed to increase efficiency and productivity, enhance safety and sustainability, and enable new innovations in industrial-based services, from worker assistants to predictive maintenance, visual anomaly detection, asset management and more.
The collaboration is intended to utilize Aramco Digital's 450 MHz 5G industrial network to connect intelligent edge devices powered by solutions from Qualcomm Technologies-including smartphones, rugged industrial devices, robots, drones, cameras, sensors, and other IoT devices. Aramco Digital and Qualcomm Technologies also plan to develop the capabilities to deploy, manage, and update AI models on Aramco Digital's edge AI devices.

Global

QCOM

'Qualcomm And Aramco Digital To Drive Industry Transformation Through Commercialization Of Advanced Edge AI For Industrial IoT'

EXOZ

eXoZymes shares are trading higher following Q4 reported financial results.

TZUP

Thumzup Media shares are trading higher after the company announced the expansion of its capital strategy by establishing a bitcoin-backed credit facility to provide access to non-dilutive capital.

ESOA

Energy Services of America shares are trading lower after the company reported worse-than-expected Q2 financial results.

KinderCare Learning Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) will release earnings results for the first quarter, after the <a href="https://www.benzinga.com/quote/klc/earnings">closing bell on Tuesday, May 13.</a>
Analysts expect the Lake Oswego, Oregon-based company to report quarterly earnings at 17 cents per share. KinderCare Learning projects to report quarterly revenue at $680.94 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 3, The Bear Cave released a short report on KinderCare, alleging the company is plagued by operational failures that could threaten its stock performance.
KinderCare Learning shares gained 2.7% to close at $13.53 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/KLC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>UBS analyst Joshua Chan maintained a Buy rating and cut the price target from $24 to $21 on April 15, 2025. This analyst has an accuracy rate of 65%.</li>
<li>BMO Capital analyst Jeffrey Silber maintained an Outperform rating and slashed the price target from $31 to $26 on March 24, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Goldman Sachs analyst George Tong maintained a Buy rating and cut the price target from $35 to $30 on March 21, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Baird analyst Jeffrey Mueler maintained an Outperform rating and lowered the price target from $30 to $25 on March 21, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Morgan Stanley analyst Toni Kaplan maintained an Overweight rating and cut the price target from $30 to $21 on March 21, 2025. This analyst has an accuracy rate of 67%.</li>
</ul>
Considering buying KLC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13031735/image-132-1024x577.png" alt="" class="wp-image-912986" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13031735/image-132-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13031735/image-132-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13031735/image-132-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13031735/image-132.png 1153w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45347009/top-2-tech-stocks-that-may-crash-in-q2">Top 2 Tech Stocks That May Crash In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Top Wall Street Forecasters Revamp KinderCare Learning Expectations Ahead Of Q1 Earnings

Morgan Stanley analyst Lisa De Neve maintains Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) with a Overweight and lowers the price target from $100 to $98.

Morgan Stanley Maintains Overweight on Intl Flavors & Fragrances, Lowers Price Target to $98

SONM

Sonim Technologies shares are trading lower after the company reported a year-over-year decrease in Q1 sales results.

TGEN

Tecogen shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Karyopharm Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPTI#NASDAQ">KPTI</a>) reported mixed financial results for the <a href="https://www.benzinga.com/quote/KPTI/earnings">first quarter on Monday</a>.
The company posted quarterly losses of $2.77 per share which beat the analyst consensus estimate of losses of $4.16 per share. The company reported quarterly sales of $30.02 million which missed the analyst consensus estimate of $35.24 million.
&#8220;We are pleased that our Phase 3 SENTRY trial in patients with JAKi-naïve myelofibrosis has passed its pre-specified futility analysis and continues as planned without modifications. Our conviction in this trial is further strengthened by our new data in hard-to-treat myelofibrosis patients where we observed spleen volume reduction, symptom improvement, hemoglobin stabilization and evidence of disease modification with selinexor monotherapy, addressing all four hallmarks of the disease,&#8221; said Richard Paulson, President and Chief Executive Officer of Karyopharm.
Karyopharm Therapeutics affirmed FY2025 sales guidance of $140.00 million to $155.00 million versus market estimates of $149.32 million.
Karyopharm Therapeutics shares fell 15.6% to trade at $5.17 on Tuesday.
These analysts made changes to their price targets on Karyopharm Therapeutics following earnings announcement.
<ul class="wp-block-list">
<li>Baird analyst Michael Ulz maintained Karyopharm Therapeutics with an Outperform rating and lowered the price target from $54 to $42.</li>
<li>Barclays analyst Peter Lawson maintained the stock with an Overweight rating and raised the price target from $5 to $10.</li>
<li>RBC Capital analyst Brian Abrahams maintained Karyopharm Therapeutics with an Outperform rating and lowered the price target from $34 to $33.</li>
</ul>
Considering buying KPTI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="611" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13133540/image-148-1024x611.png" alt="" class="wp-image-913954" style="width:579px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13133540/image-148-1024x611.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13133540/image-148-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13133540/image-148-768x459.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13133540/image-148.png 1107w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results

VUZI

Vuzix shares are trading higher after the company reported better-than-expected Q1 financial results.

Morgan Stanley analyst Michael Cyprys maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Equal-Weight and raises the price target from $40 to $43.

HOOD

Morgan Stanley Maintains Equal-Weight on Robinhood Markets, Raises Price Target to $43

<a href="https://www.cnbc.com/2025/05/13/trump-says-us-will-remove-all-sanctions-on-syria.html">https://www.cnbc.com/2025/05/13/trump-says-us-will-remove-all-sanctions-on-syria.html</a>
<ul>
<li>"I will be ordering the cessation of sanctions against Syria in order to give them a chance at greatness," President Donald Trump told a packed auditorium in Riyadh, Saudi Arabia.</li>
<li>Syria has been designated a state sponsor of terrorism by the U.S. government since 1979.&nbsp;</li>
<li>"Now, it's their time to shine. We're taking them all off. ... Good luck Syria," Trump said.</li>
</ul>

Politics

General

'Trump Says U.S. Will Remove All Sanctions On Syria' - CNBC

<a href="https://www.benzinga.com/topic/artificial-intelligence" target="_blank" rel="noopener">AI 과대광고</a>, 관세 공포, 지정학적 헤드라인에 휩싸인 시장에서 오늘날 트레이더는 관망하지 않고 변동성을 바로 보고 빠르게 움직이고 있다.
디렉시온(Direxion)의 자본시장 책임자인 제이크 베한(Jake Behan)은 벤징가와 독점 Q&amp;A 이메일에서 가장 적극적인 시장 참여자들은 레버리지 및 인버스 ETF를 이용해 장기적인 관점이 아닌 빠르고 확신에 찬 움직임을 보이고 있다고 전했다.
대표적인 사례는 바로 팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)이다. 5월의 <a href="https://www.benzinga.com/news/earnings/25/05/45208000/palantir-q1-earnings-revenue-beat-eps-in-line-customer-count-up-39-company-raises-guidance-citing-surging-and-ferocious-growth" target="_blank" rel="noopener">견조한 실적 발표</a> 이후, 투자자들이 회사의 AI 기반 성장세가 지속 가능한지 의문을 제기하면서 주가가 12% 이상 급락했다. 하지만 그렇다고 해서 흐름이 멈추지는 않았다.
디렉시온은 Direxion Daily PLTR Bull 2X Shares(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTU#NASDAQ">PLTU</a>)과 Direxion Daily PLTR Bear 1X Shares(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTD#NASDAQ">PLTD</a>)에서 활동이 있었으며, 이는 기술 대세 주식 팔란티어에 대한 감정이 얼마나 나뉘었는지 나타낸다.
베한은 "밸류에이션이 면밀히 검토되고 있으며 성장의 지속성이 테스트되고 있다&#8221;고 했다.
트레이더들은 중국 수요부터 AI 수익화, 자본 지출 동향에 이르기까지 모든 것을 주시하고 있지만, 이러한 견해를 전술적으로 표현하고 있다. 디렉시온의 단일 주식 상품군에서는 4월에만 36억 달러가 유입되는 등 실적과 관세를 둘러싼 대규모 움직임이 나타났으며, 이는 디렉시온의 반도체 3배 레버리지 ETF인 Direxion Daily Semiconductor Bull 3x Shares(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXL#NYSE">SOXL</a>)가 주도했다.
한편 전통적인 헤지 전략은 선호도가 떨어지고 있다. 대신 트레이더들은 특히 헤드라인에 민감한 기간 동안 빠른 헤지 도구로 -1X ETF를 활용하고 있다고 베한은 말했다. 이는 Direxion Daily Semiconductor Bear 3x Shares(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXS#NYSE">SOXS</a>), Direxion Daily AAPL Bear 1X Shares(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPD#NASDAQ">AAPD</a>), Direxion Daily FTSE China Bear 3x Shares(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YANG#NYSE">YANG</a>) 같은 인버스 펀드에서 확인할 수 있다. 이들 ETF는 관세 관련 하락과 매크로 데이터 서프라이즈 기간 동안 주간 유입을 보였다.
베한은 앞으로의 여름이 평온할 것으로 예상하지 않는다. "우리는 더 많은 변동성의 폭풍을 보게 될 것&#8221;이라고 경고하며 현재 90일 관세 유예가 만료되고 다음 실적 발표가 있을 것이라고 강조했다.
높은 변동성지수(VIX)가 아닌 일시적인 급등락이 시장 분위기를 결정할 수 있다.
상승 서프라이즈 나타날까?
베한에 따르면 노동 및 인플레이션 지표가 양호하게 나오면 시장은 위험뿐 아니라 탄력적인 성장세를 반영해 가격을 책정할 수 있다. 하지만 현재로서는 트레이더들은 장기적인 행복에 베팅하기보다는 변동성과 함께 춤을 추는 데 만족하는 듯하다.
사진: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Direxion Daily AAPL Bear 1X Shares

뉴스

에 대한 최신 뉴스 Direxion Daily AAPL Bear 1X Shares (NASDAQ:AAPD)

화요일, 5월 13, 2025

뉴스

파트너 / 기고자

벤징가 글로벌